文献速递临床生化

采用国际质量目标评估新型HbA1c方法以供IFCC和NGSP参考网络采纳

Evaluating new HbA1c methods for adoption by the IFCC and NGSP reference networks using international quality targets.
PubMed 文献 · Clin Chem Lab Med · 2017-01-01

作为HbA1c参考实验室,需具备覆盖多种测量原理的准确精密方法。本研究依据认证评估方案,评价Abbott酶法(Architect c4000)、Roche Gen.3 HbA1c(Cobas c513)和Tosoh G11的性能,并评估血红蛋白变异体干扰及与IFCC和NGSP参考系统的一致性。三种方法在46 mmol/mol(6.4%)和72 mmol/mol(8.7%)处CV均<3%(SI单位)和<2%(NGSP单位),通过NGSP标准,常见Hb变异体无临床显著干扰,均适合临床应用。

要点

  • 三种HbA1c方法在46和72 mmol/mol处CV均<3%(SI)和<2%(NGSP)。
  • Abbott酶法和Roche Gen.3已成为IFCC和NGSP官方认证的SRMP。
  • 三种方法对常见Hb变异体无临床显著干扰。

核心结论

  • 三种HbA1c方法性能良好,均适合临床HbA1c分析应用。
  • Abbott酶法(Architect c4000)和Roche Gen.3 HbA1c(Cobas c513)已成为IFCC和NGSP官方认证的SRMP。

研究设计与样本

  • 采用认证评估方案,评估Abbott酶法、Roche Gen.3和Tosoh G11三种HbA1c方法。
  • 评估内容包括血红蛋白变异体影响、其他潜在干扰及与IFCC和NGSP参考系统的一致性。

主要发现

  • 三种方法在46 mmol/mol(6.4%)和72 mmol/mol(8.7%)处CV均<3%(SI单位)和<2%(NGSP单位)。
  • 与六种二级参考测量程序(SRMP)比较,三种方法均通过NGSP标准。
  • Sigma值为Abbott酶法8.6、Roche Cobas c513 3.3、Tosoh G11 6.9。
  • 三种方法对常见Hb变异体未检测到临床显著干扰。

关键数值与推荐

  • CV<3%(SI单位)和<2%(NGSP单位)在46 mmol/mol(6.4%)和72 mmol/mol(8.7%)处。
  • NGSP标准:与六种SRMP比较通过。
  • Sigma值:Abbott酶法8.6、Roche Cobas c513 3.3、Tosoh G11 6.9。

临床怎么用

  • 三种方法均可用于临床HbA1c分析。
  • Sigma指标以图形呈现,可区分性能良好与优秀。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: As a reference laboratory for HbA1c, it is essential to have accurate and precise HbA1c methods covering a range of measurement principles. We report an evaluation of the Abbott Enzymatic (Architect c4000), Roche Gen.3 HbA1c (Cobas c513) and Tosoh G11 using different quality targets. METHODS: The effect of hemoglobin variants, other potential interferences and the performance in comparison to both the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) and the National Glycohemoglobin Standardization Program (NGSP) reference systems was assessed using certified evaluation protocols. RESULTS: Each of the evaluated HbA1c methods had CVs <3% in SI units and <2% in NGSP units at 46 mmol/mol (6.4%) and 72 mmol/mol (8.7%) and passed the NGSP criteria when compared with six secondary reference measurement procedures (SRMPs). Sigma was 8.6 for Abbott Enzymatic, 3.3 for Roche Cobas c513 and 6.9 for Tosoh G11. No clinically significant interference was detected for the common Hb variants for the three methods. CONCLUSIONS: All three methods performed well and are suitable for clinical application in the analysis of HbA1c. Partly based on the result of this study, the Abbott Enzymatic method on the Architect c4000 and the Roche Gen.3 HbA1c on the Cobas c513 are now official, certified IFCC and NGSP SRMPs in the IFCC and NGSP networks. Sigma metrics quality criteria presented in a graph distinguish between good and excellent performance.

来源:Clin Chem Lab Med,查看原文。版权归原作者所有。

引用

  1. Lenters-Westra E, English E. Evaluating new HbA1c methods for adoption by the IFCC and NGSP reference networks using international quality targets. Clin Chem Lab Med. 2017. PMID: 28432844. doi:10.1515/cclm-2017-0109

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。